Inspire Medical Systems Inc
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
INSP$62.31-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations and Comprehensive Income (Loss)
Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited)
(in thousands, except share and per share amounts)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenue | $201,317 | $164,010 |
| Cost of goods sold | 30,709 | 24,757 |
| Gross profit | 170,608 | 139,253 |
| Operating expenses: | ||
| Research and development | 27,803 | 28,850 |
| Selling, general and administrative | 144,290 | 125,621 |
| Total operating expenses | 172,093 | 154,471 |
| Operating loss | (1,485) | (15,218) |
| Other (income) expense: | ||
| Interest and dividend income | (5,066) | (5,923) |
| Other (income) expense, net | (578) | 60 |
| Total other income | (5,644) | (5,863) |
| Income (loss) before income taxes | 4,159 | (9,355) |
| Income taxes | 1,167 | 650 |
| Net income (loss) | 2,992 | (10,005) |
| Other comprehensive income (loss): | ||
| Foreign currency translation loss | (300) | (134) |
| Unrealized loss on investments | (9) | (542) |
| Total comprehensive income (loss) | $2,683 | $(10,681) |
| Net income (loss) per share: | ||
| Basic | $0.10 | $(0.34) |
| Diluted | $0.10 | $(0.34) |
| Weighted average shares outstanding: | ||
| Basic | 29,702,358 | 29,615,166 |
| Diluted | 30,311,476 | 29,615,166 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.